ACER
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | ACEYY |
| ISIN: | TW0002353000 |
ACER news, videos and press releases - Page 6
For more news please use our advanced search feature.
ACER - More news...
ACER - More news...
- 07/09/2019 - 09:24 Acer Reports June Consolidated Revenues of NT$24.48 Billion, Up 4.3% Year-on-Year
- 07/03/2019 - 21:54 LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acer Therapeutics Inc. To Contact The Firm
-
06/29/2019 - 19:56
Acer Therapeutics Inc. - ACER Stock Chart Technical Analysis for 06-29-2019
- 06/25/2019 - 12:30 Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of EDSIVO™ (celiprolol) in vEDS Patients
- 05/31/2019 - 12:30 Acer Therapeutics Announces Poster Presentation at Society for Vascular Medicine Annual Meeting
- 05/23/2019 - 12:30 Acer Therapeutics to Present at Upcoming Investor Conferences
- 05/14/2019 - 20:01 Acer Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
- 05/08/2019 - 11:16 Acer Reports Q1 2019 Results: Consolidated Revenues NT$54.70 Billion, Net Income NT$706 Million, EPS NT$0.23
- 04/16/2019 - 12:30 Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data
- 04/09/2019 - 08:47 Acer Reports March Consolidated Revenues of NT$23.55 Billion, Up 62.8% Month-on-month
- 03/20/2019 - 11:03 Acer Reports Fiscal 2018 Net Income NT$3.06 Billion, Up 8.7% YoY; EPS NT$1.01, Highest in Eight Years
- 03/13/2019 - 15:17 CORRECTING and REPLACING -- Acer Therapeutics to Participate in Upcoming Investor Conferences
- 03/13/2019 - 12:30 Acer Therapeutics to Participate in Upcoming Investor Conferences
- 03/08/2019 - 11:30 Acer Reports February Consolidated Revenues of NT$14.47 Billion
- 03/07/2019 - 21:01 Acer Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
- 02/14/2019 - 11:52 Acer Reports January Consolidated Revenues of NT$16.66 Billion
- 01/09/2019 - 11:12 Acer Reports 4.1% YoY Growth with December Consolidated Revenues of NT$21.83 Billion
- 12/26/2018 - 13:30 Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO™ for the Treatment of vEDS
- 12/17/2018 - 13:30 Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer
- 12/10/2018 - 08:27 Acer Reports Consolidated Revenues for November at NT$22.17 Billion
- 11/09/2018 - 21:01 Acer Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
- 11/07/2018 - 11:46 Acer Reports Q3 2018 Results: Highest Operating Income of NT$1.17 Billion for Q3 in Eight Years
- 10/29/2018 - 12:30 Acer Therapeutics Submits NDA for EDSIVO™ for the Treatment of vEDS
- 10/08/2018 - 13:18 Acer Reports Near 8% YoY Growth in Consolidated Revenues for Q3 2018, Marking A Record High This Year at NT$65.33 Billion
- 10/04/2018 - 02:12 Acer Listed on Dow Jones Sustainability Indices for Fifth Straight Year
- 09/10/2018 - 12:25 Acer Reports Consolidated Revenues for August at NT$22.36 Billion, Up 11.5% Year-on-year
- 08/20/2018 - 12:30 Acer Therapeutics to Present at the 20th Annual H.C. Wainwright Conference
- 08/13/2018 - 20:01 Acer Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
- 08/09/2018 - 11:52 Acer Reports Consolidated Revenues for July at NT$20.07 Billion, Up 10.5% Year-on-year
- 08/08/2018 - 10:44 Acer Reports Q2 2018 Results: Highest Net Income of NT$881 Million for Q2 in Eight Years
